• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Cataract laser system wins technology award

Article

A laser system for cataract surgery that combines a femtosecond laser, three-dimensional optical coherence tomography (OCT) imaging, and a proprietary pattern scanning technology (Catalys Precision Laser System, OptiMedica) has been selected as a winner of R&D Magazine’s R&D 100 award.

Sunnyvale, CA-A laser system for cataract surgery that combines a femtosecond laser, three-dimensional optical coherence tomography (OCT) imaging, and a proprietary pattern scanning technology (Catalys Precision Laser System, OptiMedica) has been selected as a winner of R&D Magazine’s R&D 100 award.

Selected by an independent judging panel and the editors of R&D Magazine, the R&D 100 awards recognize the 100 most technologically significant products introduced into the marketplace over the past year.

“This award is a wonderful confirmation of what we are seeing from cataract surgeons around the world who are choosing [our laser system] because they believe it the best technology platform for laser cataract surgery,” said David D. Scott, OptiMedica’s vice president of research and development. “Our goal was to create a system that delivers unsurpassed precision and leaves nothing to chance. It is an honor to have the distinguished panel of R&D 100 judges reward our efforts with this distinction.”

Catalys is FDA 510(k) market cleared and CE mark approved for performing capsulotomy and/or lens fragmentation, and is also CE mark approved for performing corneal incisions during cataract procedures.

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Videos
Elias Kahan, MD, speaks at the 2024 ARVO meeting
Andrew Pucker, OD, PhD
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
© 2024 MJH Life Sciences

All rights reserved.